ST. LOUIS — Thomas Burris, Ph.D. has been named the William Beaumont Professor and Chair of Pharmacological and Physiological Science. Joining SLU from The Scripps Research Institute in Florida where he was a professor in the department of molecular therapeutics, Burris conducts research in chemical biology and nuclear receptors.
|Thomas Burris, Ph.D.|
“We’re delighted to welcome Dr. Burris to SLU,” said Philip Alderson, M.D., dean of the school of medicine and vice president for medical affairs. “Tom’s nuclear receptor disorders research has great potential for future exploration in metabolic diseases and in cancer.”
Burris serves on the editorial boards of Molecular Pharmacology, the Journal of Biological Chemistry and Molecular Endocrinology, among others. He is an ad hoc manuscript reviewer for numerous journals including Science, Nature, the American Journal of Physiology and the Journal of Neuroscience.
Read about Burris's research on a new drug that increases exercise endurance in a recent New York Times article.
Burris has received numerous honors and awards including fellowships in the American Association for the Advancement of Science and the American Heart Association. He is the author of over 120 manuscripts and two books and holds four patents.
Burris’s leadership follows that of Thomas Westfall, Ph.D., who retired earlier this year.
Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious disease.